Text Size

Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use

This study has been completed.
Sponsor:
Collaborators:
Cambridge Health Alliance
Tufts Medical Center
Harvard School of Dental Medicine
Fallon Clinic
Information provided by (Responsible Party):
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00907309
First received: May 20, 2009
Last updated: January 2, 2013
Last verified: January 2013
History of Changes
  Purpose

The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.


Condition Intervention Phase
Use; Tobacco, Harmful
Alcohol Abuse
Drug Abuse
 Behavioral: iMET
Behavioral: iMET/TE
 Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Dental and Medical Office Internet/Intranet Motivational Enhancement Therapy to Reduce Teen Tobacco, Alcohol, and Drug Use

Resource links provided by NLM:

MedlinePlus related topics: Marijuana
U.S. FDA Resources

Further study details as provided by Children's Hospital Boston:

Primary Outcome Measures:
  • Frequency of tobacco, alcohol, marijuana, and other drug use [ Time Frame: 3 months, 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Rates of initiation and cessation of tobacco, alcohol, marijuana and other drug use [ Time Frame: 3 months, 6 months ] [ Designated as safety issue: No ]

Enrollment: 121
Study Start Date: September 2010
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Treatment as usual
Participants will receive treatment as usual from their provider.
Experimental: iMET
Participants will receive the iMET intervention.
 Behavioral: iMET
Participants will receive the iMET intervention
Experimental: iMET/TE
Participants will receive the iMET intervention and Technological Extenders (TEs).
 Behavioral: iMET/TE
Participants will receive the iMET intervention and also receive TEs (Technological Extenders)

Detailed Description:

We have previously developed and tested in a treatment population a promising MET program for alcohol and drug use. We will broaden the MET intervention to also target tobacco use and convert the new materials into a self-administered format.

  Eligibility

Ages Eligible for Study:   12 Years to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 12-21 years old
  • Coming for routine care

Exclusion Criteria:

  • Medically or emotionally unstable day of visit
  • Already receiving behavioral health services
  • Cannot read/understand English
  • Will not be available for post-tests
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00907309

Locations
United States, Massachusetts
Children's Hospital Boston
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Children's Hospital Boston
Cambridge Health Alliance
Tufts Medical Center
Harvard School of Dental Medicine
Fallon Clinic
Investigators
Principal Investigator: John R. Knight, MD Children's Hospital Boston
  More Information

Additional Information:
web site of Center for Adolescent Substance Abuse Research at Children's Hospital Boston  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Children's Hospital Boston
ClinicalTrials.gov Identifier: NCT00907309     History of Changes
Other Study ID Numbers: iMET RFA-OD-09-003
Study First Received: May 20, 2009
Last Updated: January 2, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital Boston:
alcohol abuse
marijuana abuse
drug abuse
tobacco use
tobacco dependence

Additional relevant MeSH terms:
Substance-Related Disorders
Alcoholism
Mental Disorders
Alcohol-Related Disorders

ClinicalTrials.gov processed this record on June 17, 2013